Caris Life Sciences, Inc. - Common Stock, par value $0.001 per share (CAI)

177 filings reported holding CAI - Caris Life Sciences, Inc. - Common Stock, par value $0.001 per share as of Q3 2025.
Caris Life Sciences, Inc. - Common Stock, par value $0.001 per share (CAI) has 137 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 113,389,372 shares of 277,487,877 outstanding shares and own 40.86% of the company stock.
Largest 10 shareholders include Sixth Street Partners Management Company, L.P. (24,385,399 shares), COATUE MANAGEMENT LLC (10,142,198 shares), FMR LLC (9,633,435 shares), T. Rowe Price Investment Management, Inc. (8,025,759 shares), BRAIDWELL LP (7,316,142 shares), PRICE T ROWE ASSOCIATES INC /MD/ (6,924,745 shares), Silver Lake Group, L.L.C. (5,291,006 shares), NEUBERGER BERMAN GROUP LLC (4,345,042 shares), MILLENNIUM MANAGEMENT LLC (3,938,072 shares), and PointState Capital LP (3,883,721 shares).
This table shows the top 137 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.